Veracyte VCYT Stock
Veracyte Price Chart
Veracyte VCYT Financial and Trading Overview
| Veracyte stock price | 31.47 USD |
| Previous Close | 26.4 USD |
| Open | 25.93 USD |
| Bid | 0 USD x 1000 |
| Ask | 0 USD x 2200 |
| Day's Range | 25.55 - 26.68 USD |
| 52 Week Range | 14.92 - 32.4 USD |
| Volume | 514.82K USD |
| Avg. Volume | 654.17K USD |
| Market Cap | 1.92B USD |
| Beta (5Y Monthly) | 1.379577 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0.31 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 31.67 USD |
VCYT Valuation Measures
| Enterprise Value | 1.79B USD |
| Trailing P/E | N/A |
| Forward P/E | -66.3 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 6.1717815 |
| Price/Book (mrq) | 1.7753382 |
| Enterprise Value/Revenue | 5.754 |
| Enterprise Value/EBITDA | -301.403 |
Trading Information
Veracyte Stock Price History
| Beta (5Y Monthly) | 1.379577 |
| 52-Week Change | 55.99% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 32.4 USD |
| 52 Week Low | 14.92 USD |
| 50-Day Moving Average | 24 USD |
| 200-Day Moving Average | 23.17 USD |
VCYT Share Statistics
| Avg. Volume (3 month) | 654.17K USD |
| Avg. Daily Volume (10-Days) | 581.84K USD |
| Shares Outstanding | 72.42M |
| Float | 72.04M |
| Short Ratio | 5.85 |
| % Held by Insiders | 1.15% |
| % Held by Institutions | 105.45% |
| Shares Short | 3.99M |
| Short % of Float | 6.26% |
| Short % of Shares Outstanding | 5.51% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -9.70% |
| Operating Margin (ttm) | -10.27% |
| Gross Margin | 65.38% |
| EBITDA Margin | -1.90% |
Management Effectiveness
| Return on Assets (ttm) | -1.71% |
| Return on Equity (ttm) | -2.78% |
Income Statement
| Revenue (ttm) | 311.18M USD |
| Revenue Per Share (ttm) | 4.34 USD |
| Quarterly Revenue Growth (yoy) | 21.60% |
| Gross Profit (ttm) | 194.95M USD |
| EBITDA | -5941000 USD |
| Net Income Avi to Common (ttm) | -30190000 USD |
| Diluted EPS (ttm) | -0.42 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 177.89M USD |
| Total Cash Per Share (mrq) | 2.46 USD |
| Total Debt (mrq) | 13.99M USD |
| Total Debt/Equity (mrq) | 1.29 USD |
| Current Ratio (mrq) | 4.492 |
| Book Value Per Share (mrq) | 14.938 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 14.24M USD |
| Levered Free Cash Flow (ttm) | 22.41M USD |
Profile of Veracyte
| Country | United States |
| State | CA |
| City | South San Francisco |
| Address | 6000 Shoreline Court |
| ZIP | 94080 |
| Phone | 650 243 6300 |
| Website | https://www.veracyte.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 787 |
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; Percepta Nasal Swab Test for lung cancer diagnosis; Envisia Genomic Classifier for diagnosing interstitial lung disease, including idiopathic pulmonary fibrosis; and Immunoscore Colon Cancer test for colon cancer diagnosis. It is also developing Percepta Genomic Atlas to help inform lung cancer treatment decisions; Envisia Classifier, the nCounter analysis system; and LymphMark for lymphoma subtyping test. Veracyte, Inc. has technology licensing and collaboration arrangements with Johnson & Johnson; Acerta Pharma; and CareDx. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
Q&A For Veracyte Stock
What is a current VCYT stock price?
Veracyte VCYT stock price today per share is 31.47 USD.
How to purchase Veracyte stock?
You can buy VCYT shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Veracyte?
The stock symbol or ticker of Veracyte is VCYT.
Which industry does the Veracyte company belong to?
The Veracyte industry is Biotechnology.
How many shares does Veracyte have in circulation?
The max supply of Veracyte shares is 77.94M.
What is Veracyte Price to Earnings Ratio (PE Ratio)?
Veracyte PE Ratio is 101.50000000 now.
What was Veracyte earnings per share over the trailing 12 months (TTM)?
Veracyte EPS is 0.31 USD over the trailing 12 months.
Which sector does the Veracyte company belong to?
The Veracyte sector is Healthcare.
Veracyte VCYT included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16800.06 USD — |
+0.55
|
1.03B USD — | 16744.97 USD — | 16802.38 USD — | — - | 1.03B USD — |
| NASDAQ Composite Total Return I XCMP | 20606.02 USD — |
+0.75
|
— — | 20497.5 USD — | 20643.2 USD — | — - | — — |
| Nasdaq US 700 Small Cap Value I NQUS700SCV | 1848.95 USD — |
+0.23
|
— — | 1842.64 USD — | 1849.08 USD — | — - | — — |
| NASDAQ Global Market Composite NQGM | 1854.12 USD — |
+0.77
|
— — | 1840.92 USD — | 1855.86 USD — | — - | — — |
| Stlmt ID NASDAQ Biotechnology NBX | 4126.44 USD — |
+0.05
|
— — | 3927.42 USD — | 4126.44 USD — | — - | — — |
| Nasdaq US 700 Small Cap Value N NQUS700SCVN | 2081.13 USD — |
+0.23
|
— — | 2074.08 USD — | 2081.33 USD — | — - | — — |
| Nasdaq US 700 Small Cap Index NQUS700SC | 2032.76 USD — |
+0.41
|
— — | 2024.76 USD — | 2033.05 USD — | — - | — — |
| Nasdaq AlphaDEX Multi Cap Growt NQDXUSMLTCG | 2703.9 USD — |
+0.42
|
— — | 2691.56 USD — | 2705.64 USD — | — - | — — |
| NASDAQ Biotechnology NBI | 4126.55 USD — |
+0.25
|
— — | 4101.67 USD — | 4126.55 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 916.53 USD — |
+0.54
|
— — | 911.02 USD — | 916.62 USD — | — - | — — |
- {{ link.label }} {{link}}